Recipient of federal assistance · SEATTLE, WA

AVM BIOTECHNOLOGY, INC.

AVM BIOTECHNOLOGY, INC. received $0 in federal grants and other assistance in FY2026, on 2 actions, −100% vs FY2025. It has no federal contracts in the loaded years. Since FY2022: $5M.

Assistance · FY2026
$0
New awards
0
Actions
2
Since FY2022
$5M
UEI
D29NFMS3DJJ8
Location
SEATTLE, WA
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 2.1MFY2022
  2. 2MFY2023
  3. 0FY2024
  4. 992.4KFY2025
  5. 0FY2026

Top programs · Awarding agencies

Obligations in FY2026.

Largest awards

  1. TARGETED LYMPHOABLATION AS AN ALTERNATIVE TO HSCT TO CURE T1D - PROJECT SUMMARY WITH INSULIN BEING THE ONLY APPROVED TREATMENT OF TYPE 1…$1.6M
    93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Mar 30, 2022 – Aug 21, 2026· R44DK121634
  2. IMMUNOMODULATORY AVM0703 TO BRIDGE RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS TO CAR-T CELL IMMUNOTHERAPY - PROJECT SUMMARY…$992.4K
    93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Sep 8, 2025 – Sep 10, 2026· R44CA310370

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2022–FY2026.